search
Back to results

Diet and Body Composition (CENTRAL)

Primary Purpose

Obesity

Status
Completed
Phase
Phase 3
Locations
Israel
Study Type
Interventional
Intervention
Weight-loss diet strategy (+) exercise (PA)
weight loss (-) exercise (PA)
Sponsored by
Ben-Gurion University of the Negev
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring abdominal obesity

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Elevated waist circumference:

    • Men: > 40 inches (102 cm)
    • Women> 35 inches (88 cm)
  • Poor dieters with TG>150mg/dL and high-density-lipoprotein cholesterol [HDL-c] <40 mg/dL for men and <50 mg/dL for women

Exclusion Criteria:

  • Pregnant or lactating women
  • Serum creatinine LT 2 mg/dl
  • Disturbed liver function (LT 3 fold level of ALT and AST enzymes)
  • Active cancer
  • Individuals who cannot start physical activity in the gym
  • Individuals that are highly physically active (more than 4 hours/week)
  • Active in other nutritional trial

Sites / Locations

  • nuclear research center Negev

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

low fat diet

low carb diet

Arm Description

Weight-loss diet strategy

Weight-loss diet strategy

Outcomes

Primary Outcome Measures

body fat composition
changes in body fat (MRI)
obesity
changes in weight
abdominal obesity
changes in waist circumference

Secondary Outcome Measures

Lipid profile
Changes in lipid biomarkers: total cholesterol (mg/dL), triglycerides (mg/dL), HDLc (mg/dL), LDLc (mg/dL) (blood draw)
Glycemic control
Changes in fasting glucose (mg/dL) (blood draw)
Glycemic control
Changes in insulin (μIU/mL) (blood draw)
Inflammatory state
Changes hsCRP (mg/L) (blood draw)
Metabolomic
Changes in sub-lipids (blood draw)
Metabolomic
Changes in sub-proteins ( blood draw)
Liver function (blood biomarkers)
Changes in ALT (U/l), AST (U/l), ALKP (U/I), GGT (U/l) (blood draw)
Genetic signature
SNPs (variants) associated with fat distribution and visceral fat (blood draw)
Epigenetics
changes in genes' methylation (blood draw)
Epigenetics
changes in mRNAs (blood draw)

Full Information

First Posted
February 8, 2012
Last Updated
October 21, 2020
Sponsor
Ben-Gurion University of the Negev
search

1. Study Identification

Unique Protocol Identification Number
NCT01530724
Brief Title
Diet and Body Composition
Acronym
CENTRAL
Official Title
Effect of Weight-loss Diet Strategies and Exercise on Dynamics of Body Fat Depots and Metabolic Rate
Study Type
Interventional

2. Study Status

Record Verification Date
October 2020
Overall Recruitment Status
Completed
Study Start Date
October 2012 (undefined)
Primary Completion Date
April 2014 (Actual)
Study Completion Date
April 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ben-Gurion University of the Negev

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators hypothesize that differential dynamics in fat depots in response to two opposing dietary strategies mediate the beneficial metabolic effects during weight loss and regain phases.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
abdominal obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Factorial Assignment
Masking
Care ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
224 (Actual)

8. Arms, Groups, and Interventions

Arm Title
low fat diet
Arm Type
Experimental
Arm Description
Weight-loss diet strategy
Arm Title
low carb diet
Arm Type
Experimental
Arm Description
Weight-loss diet strategy
Intervention Type
Other
Intervention Name(s)
Weight-loss diet strategy (+) exercise (PA)
Intervention Description
Weight-loss diet strategy with a free gym membership; monthly 60-minute educational workshops; 3 sessions of workout per week of mostly aerobic training
Intervention Type
Other
Intervention Name(s)
weight loss (-) exercise (PA)
Intervention Description
Weight-loss diet strategy without exercise
Primary Outcome Measure Information:
Title
body fat composition
Description
changes in body fat (MRI)
Time Frame
0, 6,18 months
Title
obesity
Description
changes in weight
Time Frame
0, 6, 18 months
Title
abdominal obesity
Description
changes in waist circumference
Time Frame
0, 6, 18 months
Secondary Outcome Measure Information:
Title
Lipid profile
Description
Changes in lipid biomarkers: total cholesterol (mg/dL), triglycerides (mg/dL), HDLc (mg/dL), LDLc (mg/dL) (blood draw)
Time Frame
0, 6, 18 months
Title
Glycemic control
Description
Changes in fasting glucose (mg/dL) (blood draw)
Time Frame
0, 6, 18 months
Title
Glycemic control
Description
Changes in insulin (μIU/mL) (blood draw)
Time Frame
0, 6, 18 months
Title
Inflammatory state
Description
Changes hsCRP (mg/L) (blood draw)
Time Frame
0, 6, 18 months
Title
Metabolomic
Description
Changes in sub-lipids (blood draw)
Time Frame
0, 6, 18 months
Title
Metabolomic
Description
Changes in sub-proteins ( blood draw)
Time Frame
0, 6, 18 months
Title
Liver function (blood biomarkers)
Description
Changes in ALT (U/l), AST (U/l), ALKP (U/I), GGT (U/l) (blood draw)
Time Frame
0, 6, 18 months
Title
Genetic signature
Description
SNPs (variants) associated with fat distribution and visceral fat (blood draw)
Time Frame
baseline
Title
Epigenetics
Description
changes in genes' methylation (blood draw)
Time Frame
0, 6, 18 months
Title
Epigenetics
Description
changes in mRNAs (blood draw)
Time Frame
0, 6, 18 months

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Elevated waist circumference: Men: > 40 inches (102 cm) Women> 35 inches (88 cm) Poor dieters with TG>150mg/dL and high-density-lipoprotein cholesterol [HDL-c] <40 mg/dL for men and <50 mg/dL for women Exclusion Criteria: Pregnant or lactating women Serum creatinine LT 2 mg/dl Disturbed liver function (LT 3 fold level of ALT and AST enzymes) Active cancer Individuals who cannot start physical activity in the gym Individuals that are highly physically active (more than 4 hours/week) Active in other nutritional trial
Facility Information:
Facility Name
nuclear research center Negev
City
Dimona
Country
Israel

12. IPD Sharing Statement

Citations:
PubMed Identifier
18635428
Citation
Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Bluher M, Stumvoll M, Stampfer MJ; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008 Jul 17;359(3):229-41. doi: 10.1056/NEJMoa0708681. Erratum In: N Engl J Med. 2009 Dec 31;361(27):2681.
Results Reference
background
PubMed Identifier
35657082
Citation
Heianza Y, Krohn K, Yaskolka Meir A, Wang X, Ziesche S, Ceglarek U, Bluher M, Keller M, Kovacs P, Shai I, Qi L. Changes in Circulating miR-375-3p and Improvements in Visceral and Hepatic Fat Contents in Response to Lifestyle Interventions: The CENTRAL Trial. Diabetes Care. 2022 Aug 1;45(8):1911-1913. doi: 10.2337/dc21-2517.
Results Reference
derived
PubMed Identifier
35348584
Citation
Heianza Y, Krohn K, Xue Q, Yaskolka Meir A, Ziesche S, Ceglarek U, Bluher M, Keller M, Kovacs P, Shai I, Qi L. Changes in circulating microRNAs-99/100 and reductions of visceral and ectopic fat depots in response to lifestyle interventions: the CENTRAL trial. Am J Clin Nutr. 2022 Jul 6;116(1):165-172. doi: 10.1093/ajcn/nqac070.
Results Reference
derived
PubMed Identifier
34836081
Citation
Tsaban G, Bilitzky-Kopit A, Yaskolka Meir A, Zelicha H, Gepner Y, Shelef I, Orr O, Chassidim Y, Sarusi B, Ceglarek U, Stumvoll M, Bluher M, Stampfer MJ, Shai I, Schwarzfuchs D. The Effect of Weight-Loss Interventions on Cervical and Chin Subcutaneous Fat Depots; the CENTRAL Randomized Controlled Trial. Nutrients. 2021 Oct 27;13(11):3827. doi: 10.3390/nu13113827.
Results Reference
derived
PubMed Identifier
33938135
Citation
Yaskolka Meir A, Keller M, Muller L, Bernhart SH, Tsaban G, Zelicha H, Rinott E, Kaplan A, Gepner Y, Shelef I, Schwarzfuchs D, Ceglarek U, Stadler P, Bluher M, Stumvoll M, Kovacs P, Shai I. Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial. Liver Int. 2021 Sep;41(9):2101-2111. doi: 10.1111/liv.14916. Epub 2021 May 28.
Results Reference
derived
PubMed Identifier
33663610
Citation
Yaskolka Meir A, Keller M, Bernhart SH, Rinott E, Tsaban G, Zelicha H, Kaplan A, Schwarzfuchs D, Shelef I, Gepner Y, Li J, Lin Y, Bluher M, Ceglarek U, Stumvoll M, Stadler PF, Stampfer MJ, Kovacs P, Liang L, Shai I. Lifestyle weight-loss intervention may attenuate methylation aging: the CENTRAL MRI randomized controlled trial. Clin Epigenetics. 2021 Mar 4;13(1):48. doi: 10.1186/s13148-021-01038-0.
Results Reference
derived
PubMed Identifier
33634382
Citation
Gepner Y, Goldstein N, Shelef I, Schwarzfuchs D, Zelicha H, Meir AY, Tsaban G, Grossman E. Dissociation Between Long-term Weight Loss Intervention and Blood Pressure: an 18-month Randomized Controlled Trial. J Gen Intern Med. 2021 Aug;36(8):2300-2306. doi: 10.1007/s11606-021-06655-2. Epub 2021 Feb 25.
Results Reference
derived
PubMed Identifier
31075323
Citation
Gepner Y, Shelef I, Komy O, Cohen N, Schwarzfuchs D, Bril N, Rein M, Serfaty D, Kenigsbuch S, Zelicha H, Yaskolka Meir A, Tene L, Bilitzky A, Tsaban G, Chassidim Y, Sarusy B, Ceglarek U, Thiery J, Stumvoll M, Bluher M, Stampfer MJ, Rudich A, Shai I. The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content. J Hepatol. 2019 Aug;71(2):379-388. doi: 10.1016/j.jhep.2019.04.013. Epub 2019 May 8.
Results Reference
derived
PubMed Identifier
29576369
Citation
Tene L, Shelef I, Schwarzfuchs D, Gepner Y, Yaskolka Meir A, Tsaban G, Zelicha H, Bilitzky A, Komy O, Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Chassidim Y, Sarusy B, Ceglarek U, Stumvoll M, Bluher M, Thiery J, Stampfer MJ, Rudich A, Shai I. The effect of long-term weight-loss intervention strategies on the dynamics of pancreatic-fat and morphology: An MRI RCT study. Clin Nutr ESPEN. 2018 Apr;24:82-89. doi: 10.1016/j.clnesp.2018.01.008. Epub 2018 Feb 6.
Results Reference
derived
PubMed Identifier
29190720
Citation
Gepner Y, Shelef I, Schwarzfuchs D, Cohen N, Bril N, Rein M, Tsaban G, Zelicha H, Yaskolka Meir A, Tene L, Sarusy B, Rosen P, Hoffman JR, Stout JR, Thiery J, Ceglarek U, Stumvoll M, Bluher M, Stampfer MJ, Shai I. Intramyocellular triacylglycerol accumulation across weight loss strategies; Sub-study of the CENTRAL trial. PLoS One. 2017 Nov 30;12(11):e0188431. doi: 10.1371/journal.pone.0188431. eCollection 2017.
Results Reference
derived
PubMed Identifier
29142011
Citation
Gepner Y, Shelef I, Schwarzfuchs D, Zelicha H, Tene L, Yaskolka Meir A, Tsaban G, Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Komy O, Wolak A, Chassidim Y, Golan R, Avni-Hassid H, Bilitzky A, Sarusi B, Goshen E, Shemesh E, Henkin Y, Stumvoll M, Bluher M, Thiery J, Ceglarek U, Rudich A, Stampfer MJ, Shai I. Effect of Distinct Lifestyle Interventions on Mobilization of Fat Storage Pools: CENTRAL Magnetic Resonance Imaging Randomized Controlled Trial. Circulation. 2018 Mar 13;137(11):1143-1157. doi: 10.1161/CIRCULATIONAHA.117.030501. Epub 2017 Nov 15.
Results Reference
derived
PubMed Identifier
28814394
Citation
Tsaban G, Wolak A, Avni-Hassid H, Gepner Y, Shelef I, Henkin Y, Schwarzfuchs D, Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Tene L, Zelicha H, Yaskolka-Meir A, Komy O, Bilitzky A, Chassidim Y, Ceglarek U, Stumvoll M, Bluher M, Thiery J, Dicker D, Rudich A, Stampfer MJ, Shai I. Dynamics of intrapericardial and extrapericardial fat tissues during long-term, dietary-induced, moderate weight loss. Am J Clin Nutr. 2017 Oct;106(4):984-995. doi: 10.3945/ajcn.117.157115. Epub 2017 Aug 16.
Results Reference
derived
PubMed Identifier
28501343
Citation
Zelicha H, Schwarzfuchs D, Shelef I, Gepner Y, Tsaban G, Tene L, Yaskolka Meir A, Bilitzky A, Komy O, Cohen N, Bril N, Rein M, Serfaty D, Kenigsbuch S, Chassidim Y, Sarusi B, Thiery J, Ceglarek U, Stumvoll M, Bluher M, Haviv YS, Stampfer MJ, Rudich A, Shai I. Changes of renal sinus fat and renal parenchymal fat during an 18-month randomized weight loss trial. Clin Nutr. 2018 Aug;37(4):1145-1153. doi: 10.1016/j.clnu.2017.04.007. Epub 2017 May 2.
Results Reference
derived

Learn more about this trial

Diet and Body Composition

We'll reach out to this number within 24 hrs